TRPV2 and cancer: In our hands, application of TRPV2 agonist cannabidiol (CBD, 50 μM) caused increase of basal tension and enhancement of the spontaneous contraction amplitude with both effects being insignificantly smaller in cancer vs. control DSM (Supplementary Fig. 3).